Search Result "CCK-8 assay"
Novel Circular RNA CircUBAP2 Drives Tumor Progression by Regulatingthe miR-143/TFAP2B Axis in Prostate Cancer
Journal: Protein & Peptide Letters
Volume: 31 Issue: 1 Year: 2024 Page: 61-73
Author(s):
The Biology of Cholecystokinin and Gastrin Peptides
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1154-1165
Author(s): Jens F. Rehfeld, Lennart Friis-Hansen, Jens P. Goetze, Thomas V. O. Hansen
Ezetimibe Inhibits Cell Viability and Invasion by Suppressing PI3K/AKTSignaling Pathway in Human Osteosarcoma Cells
Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 11 Year: 2024 Page: 2008-2014
Author(s):
Synthesis and Biological Evaluation of Arylpiperazine Derivatives as Anticancer Agents
Journal: Letters in Organic Chemistry
Volume: 15 Issue: 1 Year: 2018 Page: 981-989
Author(s): Hong Chen,Zonglin Yang,Tao Sun,Jiangxiu Niu,Xiumei Tian,Mu Yuan
Development and Application of Fluorescence Polarization Assays in Drug Discovery
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 6 Issue: 3 Year: 2003 Page: 183-194
Author(s): T. J. Burke, K. R. Loniello, J. A. Beebe, K. M. Ervin
RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 43 Year: 2019 Page: 4630-4640
Author(s): Hu Fen,Zheng Hongmin,Wei Wei,Yang Chao,Yao Yang,Liu Bei,Sun Zhihua
Novel STAT3 Inhibitor Exerts Anti-breast Cancer Effects Both In vitro and In vivo
Journal: Letters in Drug Design & Discovery
Volume: 20 Issue: 12 Year: 2023 Page: 2070-2079
Author(s):
GDF15 Interference Regulates Proliferation, Inflammation, and Autophagyof Lipopolysaccharide-induced Mesangial Cells by Inhibiting PI3K/AKT/mTOR Signaling
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 24 Issue: 9 Year: 2024 Page: 1069-1080
Author(s):
Integrated Network Pharmacology and Cellular Assay to Explore theMechanisms of Selenized Tripterine Phytosomes (Se@Tri-PTs) AlleviatingPodocyte Injury in Diabetic Nephropathy
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 38 Year: 2023 Page: 3073-3086
Author(s):
Ginsenoside Compound K Reduces Psoriasis-related Inflammation byActivation of the Glucocorticoid Receptor in Keratinocytes
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-25
Author(s):